Evaluate the efficacy of WIV-based vaccine formulations against SARS-CoV-2 infection and disease in hamsters

Project: Other project

Project Details

StatusFinished
Effective start/end date12/1/20 → 5/31/21

Funding

  • Refana Inc: $126,079.00